These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18443475)

  • 1. Inhibition of potassium channels in critical illness.
    Lange M; Morelli A; Westphal M
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):105-10. PubMed ID: 18443475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of adenosine triphosphate-sensitive potassium channel inhibition in shock states: physiology and clinical implications.
    Lange M; Morelli A; Ertmer C; Bröking K; Rehberg S; Van Aken H; Traber DL; Westphal M
    Shock; 2007 Oct; 28(4):394-400. PubMed ID: 17577137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind, placebo-controlled crossover pilot study of a potassium channel blocker in patients with septic shock.
    Warrillow S; Egi M; Bellomo R
    Crit Care Med; 2006 Apr; 34(4):980-5. PubMed ID: 16484892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable effects of inhibiting iNOS and closing the vascular ATP-sensitive potassium channel (via its pore-forming and sulfonylurea receptor subunits) in endotoxic shock.
    O'Brien A; Stidwill RP; Clapp LH; Singer M
    Shock; 2009 May; 31(5):535-41. PubMed ID: 18838946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapy.
    Billman GE
    Pharmacol Ther; 2008 Oct; 120(1):54-70. PubMed ID: 18708091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in renal blood flow following administration of norepinephrine and phenylephrine in septic rats treated with Kir6.1 ATP-sensitive and KCa1.1 calcium-activated K+ channel blockers.
    da Rosa Maggi Sant'Helena B; Guarido KL; de Souza P; Crestani S; da Silva-Santos JE
    Eur J Pharmacol; 2015 Oct; 765():42-50. PubMed ID: 26277325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physiological properties and possible correction of adenosine triphosphate-sensitive potassium channel function].
    Chekman IS; Tarasova KV; Shevchuk VH
    Fiziol Zh (1994); 2008; 54(1):94-107. PubMed ID: 18416191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effects of glipizide (an adenosine triphosphate-sensitive potassium channel inhibitor) on cardiopulmonary hemodynamics and global oxygen transport in healthy and endotoxemic sheep.
    Lange M; Szabo C; Van Aken H; Williams W; Traber DL; Daudel F; Bröking K; Salzman AL; Bone HG; Westphal M
    Shock; 2006 Nov; 26(5):516-21. PubMed ID: 17047524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of vascular adenosine triphosphate-sensitive potassium channels by sympathetic tone during sepsis.
    Chan YL; Orie NN; Dyson A; Taylor V; Stidwill RP; Clapp LH; Singer M
    Crit Care Med; 2012 Apr; 40(4):1261-8. PubMed ID: 22425821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glibenclamide dose response in patients with septic shock: effects on norepinephrine requirements, cardiopulmonary performance, and global oxygen transport.
    Morelli A; Lange M; Ertmer C; Broeking K; Van Aken H; Orecchioni A; Rocco M; Bachetoni A; Traber DL; Landoni G; Pietropaoli P; Westphal M
    Shock; 2007 Nov; 28(5):530-5. PubMed ID: 17589379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine triphosphate-sensitive potassium channels prevent extension of myocardial ischemia to subepicardium during hemorrhagic shock.
    Nakagawa M; Hori S; Adachi T; Miyazaki K; Inoue S; Suzuki M; Mori H; Nakazawa H; Aikawa N; Ogawa S
    Shock; 2008 Aug; 30(2):178-83. PubMed ID: 18091571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of ATP-sensitive potassium channel blockers in ischemia-reperfusion-induced renal injury versus their effects on cardiac ischemia reperfusion in rats.
    Tawfik MK; Abo-Elmatty DM; Ahmed AA
    Eur Rev Med Pharmacol Sci; 2009; 13(2):81-93. PubMed ID: 19499842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ATP-sensitive potassium channel blockers on vascular hyporeactivity, mesenteric blood flow, and survival in lipopolysaccharide-induced septic shock model.
    Boz M; Atilla P; Iskit AB; Ilhan M
    Can J Physiol Pharmacol; 2016 Aug; 94(8):858-67. PubMed ID: 27239899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuously infused glipizide reverses the hyperdynamic circulation in ovine endotoxemia.
    Lange M; Williams W; Bone HG; Van Aken H; Bröking K; Morelli A; Hucklenbruch C; Daudel F; Ertmer C; Stubbe H; Traber DL; Westphal M
    Shock; 2007 Jun; 27(6):701-6. PubMed ID: 17505312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of adenosine triphosphate-sensitive potassium channel inhibitors on coronary metabolic vasodilation.
    Farouque HM; Meredith IT
    Trends Cardiovasc Med; 2007 Feb; 17(2):63-8. PubMed ID: 17292049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of levosimendan in sepsis and septic shock.
    Pinto BB; Rehberg S; Ertmer C; Westphal M
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):168-77. PubMed ID: 18443483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP-sensitive potassium channels control glioma cells proliferation by regulating ERK activity.
    Huang L; Li B; Li W; Guo H; Zou F
    Carcinogenesis; 2009 May; 30(5):737-44. PubMed ID: 19176641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouth breathing increases the pentylenetetrazole-induced seizure threshold in mice: a role for ATP-sensitive potassium channels.
    Niaki SE; Shafaroodi H; Ghasemi M; Shakiba B; Fakhimi A; Dehpour AR
    Epilepsy Behav; 2008 Aug; 13(2):284-9. PubMed ID: 18508411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP-sensitive potassium channels: a promising target for protecting neurovascular unit function in stroke.
    Sun XL; Hu G
    Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):243-52. PubMed ID: 19413600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP-sensitive potassium channel blockage attenuates cisplatin-induced renal damage: a novel molecular mechanism.
    Namazi H
    Kidney Blood Press Res; 2008; 31(3):163. PubMed ID: 18460875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.